Invention Grant
- Patent Title: Method for producing nicotinamide mononucleotide
-
Application No.: US17974381Application Date: 2022-10-26
-
Publication No.: US11959116B2Publication Date: 2024-04-16
- Inventor: Takeshi Matsuoka , Tatsuya Hirata , Masaru Yamakoshi
- Applicant: Asahi Kasei Pharma Corporation
- Applicant Address: JP Tokyo
- Assignee: ASAHI KASEI PHARMA CORPORATION
- Current Assignee: ASAHI KASEI PHARMA CORPORATION
- Current Assignee Address: JP Tokyo
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP 21175812 2021.10.27
- Main IPC: C12P19/30
- IPC: C12P19/30 ; C12N9/10

Abstract:
The present invention addresses the problem of providing a method for producing nicotinamide mononucleotide, that produces nicotinamide mononucleotide using a single enzyme and using nucleoside monophosphate, pyrophosphate, and nicotinamide as starting materials. This problem is solved by a nicotinamide mononucleotide production method that includes at least the following steps 1) and 2): 1) a first step of producing phosphoribosyl diphosphate by the action of substantially one enzyme on nucleoside monophosphate and pyrophosphate; and 2) a second step of producing nicotinamide mononucleotide by the action of only substantially the aforementioned one enzyme on nicotinamide and the phosphoribosyl diphosphate that is the product of the first step.
Public/Granted literature
- US20230125968A1 METHOD FOR PRODUCING NICOTINAMIDE MONONUCLEOTIDE Public/Granted day:2023-04-27
Information query